stockrowNatera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.
- Revenue
- +34.1%
- EPS
- +34.4%
- Free cash flow
- −85.8%
- Total debt
- −0.06%
Quarter to September 2026, against a year earlier
Follow NTRA
Alert me
Natera, Inc. (NTRA) Net income
Natera, Inc.'s net income for fiscal 2025 was −$208.2M, compared with −$190.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$164.7M. Over the past ten years it has ranged from −$547.8M (fiscal 2022) to −$70.3M (fiscal 2015); the current reading is higher than 45% of that period. Natera, Inc. ranks 47th of 49 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$208.2M | — |
| FY2024 | −$190.4M | — |
| FY2023 | −$434.8M | — |
| FY2022 | −$547.8M | — |
| FY2021 | −$471.7M | — |
| FY2020 | −$229.7M | — |
| FY2019 | −$124.8M | — |
| FY2018 | −$128.2M | — |
| FY2017 | −$137.6M | — |
| FY2016 | −$100.3M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | −$59.9M | — |
| Jun 2026 | −$67.0M | — |
| Mar 2026 | −$85.1M | — |
| Dec 2025 | $47.3M | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| A Agilent Technologies, Inc. compare | $1.4B |
| IQV IQVIA Holdings Inc. compare | $1.4B |
| IDXX IDEXX Laboratories, Inc. compare | $1.2B |
| DGX Quest Diagnostics Incorporated compare | $1.2B |
| LH Labcorp Holdings Inc. compare | $1.0B |
| MTD Mettler-Toledo International, Inc. compare | $905.6M |
| ILMN Illumina, Inc. compare | $895.0M |
| WAT Waters Corporation compare | $98.2M |
| NTRA Natera, Inc. | −$164.7M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on NTRA
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement